STERIS plc is a leading global provider of infection prevention and procedural products and services focused on healthcare, medical device, and pharmaceutical markets. The company helps customers create a healthier and safer world through a unique mix of consumables, capital equipment, and outsourced services. Its core value proposition centers on supporting patient care through comprehensive sterilization, disinfection, and surgical solutions.
Based on Q1 2026 · FQ4 FY2026 filing
Provides a comprehensive offering for healthcare providers focused on sterile processing departments and procedural centers like operating rooms and endoscopy suites. It combines infection prevention consumables and capital equipment with maintenance and outsourced instrument reprocessing services.
Prolystica Ultra Concentrate Cleaning Chemistries, automated endoscope reprocessing systems, surgical tables, surgical lights, endoscopy accessories, sterilizers, washers
Hospitals, Ambulatory surgery centers, Endoscopy suites
Supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities. The segment utilizes a technology-neutral approach to provide process validation and microbial reduction services for single-use sterile products.
contract sterilization services, laboratory testing services, accelerators, product handling automation, process controls, monitoring systems
Medical device manufacturers, Pharmaceutical manufacturers, Research institutions
Focuses on supporting biopharmaceutical and medical device manufacturing facilities, particularly those involved in aseptic manufacturing. The portfolio includes pharmaceutical-grade detergents, cleanroom disinfectants, and specialized capital equipment for decontamination.
pharmaceutical detergents, cleanroom disinfectants, vaporized hydrogen peroxide room decontamination systems, high purity water generators, pure steam generators
Biopharmaceutical manufacturers, Medical device manufacturers, Research laboratories
A leading global provider with a significant installed base of capital equipment and a comprehensive network of contract sterilization facilities.
Americas, Europe, Asia, Ireland
Hospitals, Pharmaceutical companies, Medical device OEMs
Stainless and carbon steel suppliers, Organic and inorganic chemical producers, Ethylene oxide (EO) suppliers, Radioisotope cobalt-60 suppliers, Plastic component manufacturers
Acute care hospitals, Pharmaceutical manufacturers, Medical device OEMs, Ambulatory surgery centers
Common questions about STERIS
STERIS plc is a leading global provider of infection prevention and procedural products and services focused on healthcare, medical device, and pharmaceutical markets. The company helps customers create a healthier and safer world through a unique mix of consumables, capital equipment, and outsourced services. Its core value proposition centers on supporting patient care through comprehensive sterilization, disinfection, and surgical solutions.
STERIS (STE) has a market capitalization of $20.9B and trades on NYSE.
STERIS generated $5.8B in trailing twelve-month revenue with net income of $707.8M, representing a net margin of 12.2%. Gross margin stands at 44.1%, with free cash flow of $917.1M. These figures are based on the Q4 2025 filing.
STERIS's key competitors include Ecolab, Stryker, Boston Scientific, and others. These companies compete in similar markets and product categories.
STERIS has approximately 18,179 employees.